Dermatologic drugs, pregnancy, and lactation: A conservative guide

Archives of Dermatology

Volumn 133, Issue 7, 1997, Pages 894-898

  Reed, Barbara R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; AMPHOTERICIN B; ANALGESIC AGENT; ANTI ACNE AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; AZELAIC ACID; BACITRACIN; BENZOYL PEROXIDE; CICLOPIROX; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; HALOPROGIN; HYDROQUINONE; MECLOCYCLINE; METRONIDAZOLE; NAFTIFINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORDIHYDROGUAIARETIC ACID; NYSTATIN; OXICONAZOLE; PARACETAMOL; PERMETHRIN; PSEUDOMONIC ACID; RETINOIC ACID; TERBINAFINE; UNINDEXED DRUG;

ANTIBIOTIC THERAPY; BIRTH DEFECT; CONGENITAL MALFORMATION; CORTICOSTEROID THERAPY; DRUG CONTRAINDICATION; DRUG LABELING; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LACTATION; MATERNAL DISEASE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN DISEASE; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 0030876784     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.7.894     Document Type: Review

References (39)

1. McCredie J, Kricker A, Elliott J, Forrest J. The innocent bystander; doxylamine/ dicyclomine/pyridoxine and congenital limb defects. Med J Aust. 1984;140:525-527.
2. Gold JA, Zaremski MJ, Lev ER, Shefrin DH. Daubert v Merretl Dow, the Supreme Court tackles scientific evidence in the courtroom [see comments]. JAMA. 1993; 270:2964-2967. Comment in: JAMA. 1994;271:1578.
3. Gold JA, Zaremski MJ, Lev ER, Shefrin DH. Daubert v Merretl Dow, the Supreme Court tackles scientific evidence in the courtroom [see comments]. JAMA. 1993; 270:2964-2967. Comment in: JAMA. 1994;271:1578.
4. Bertin JE, Henifin MS. Science, law, and the search for truth in the courtroom: lessons from Daubert v. Merrell Dow. J Law Med Ethics. 1994;22:6-20.
5. Neutel CI, Johansen HL. Measuring drug effectiveness by default: the case of Bendectin. Can J Public Health. 1995;86:66-70.
6. McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects, I: a meta-anatysis of the epidemiologic studies. Teratology. 1994;50:27-37.
7. Brent RL. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Reprod Toxicol. 1995;9:337-349.
8. McDonald AD. Therapeutic drugs in early pregnancy and congenital defects. J Clin Epidemiol. 1994;47:105-110.
9. Smithells RW, Sheppard S. Teratogenicity testing in humans: a method demonstrating safety of Bendectin. Teratology. 1978;17:31-35.
10. Knoury MJ, Holtzman NA. On the ability of birth defects monitoring to detect new teratogens. Am J Epidemiol. 1987;126:136-143
11. CFR 21 (pt 201.57):23, 1987.
12. CFR 21 (pt 201.57):25, 1987.
13. United States Pharmacopeial Dispensing Information: Drug Information for the Health Care Professional, Volume 1. Taunton, Mass: Rand McNally; 1995.
14. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93:137-150.
15. The WHO Working Group; Bennett PN, ed. Drugs and Human Lactation. Amsterdam, the Netherlands: Elsevier Science Publishers; 1988.
16. Briggs GG, Freeman RK, Yaffe SL. Drugs in Pregnancy and Lactation. 3rd ed. Baltimore, Md: Williams & Wilkins; 1994.
17. Berkowitz RL, Capriotti EA, Cote JR, et al. Handbook for Prescribing Medications During Pregnancy. 2nd ed. Boston, Mass: Little Brown & Co; 1986:54.
18. Hendricks SK, Smith JR, Moore DE, Brown ZA. Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. Br J Obstet Gynaecol. 1990; 97:312-316.
19. Momma K, Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol. 1990;162:1204-1210.
20. Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins. 1983;26:631-643.
21. Parkin DE. Probable Benadryl withdrawal manifestations in a newborn infant. J Pediatr. 1974;85:580.
22. Antihistamines, systemic. In: United States Pharmacopeial Dispensing Information: Drug Information for the Health Care Professional, Volume 1. Taunton, Mass: Rand McNally; 1995:302-321.
23. Turner ES, Greenberger PA, Patterson R. Management of the pregnant asthmatic patient. Ann Intern Med. 1980;6:905-918.
24. Schardein JL. Chemically Induced Birth Defects. New York, NY: Marcel Dekker; 1985:310.
25. Walker B. Induction of cleft palate in rats with antiinflammatory drugs. Teratology. 1971;4:39-42.
26. Pinsky L, Di George AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science. 1965;147:402-403.
27. Walker BE. Induction of cleft palate in rabbits by several glucocorticoids. Proc Soc Exp Biol Med. 1965;125:1281-1284.
28. Corticosteroids/corticotropin-glucocorticoid effects, systemic. In: United States Pharmacopeial Dispensing Information: Drug Information for the Health Care Professional, Volume 1. Taunton, Mass: Rand McNally; 1995:878-906.
29. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, Mass: Publishing Sciences Group; 1977:389, 391.
30. Warrell DW, Taylor R. Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet. 1968;1:117-118.
31. Fine LG. Systemic lupus erythematosus in pregnancy. Ann Intern Med. 1981; 94:667-677.
32. Lewis JH, Weingold AB, Committee on FDA-Related Matters, American College of Gastroenterology. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol. 1985;80:912-923.
33. Kraus AM. Congenital cataract and maternal steroid ingestion. J Pediatr Ophthalmol 1975;12:107-108.
34. Sidhu RK, Hawkins D. Corticosteroids. Clin Obstet Gynecol. 1981;8:383-404.
35. Katz FH, Thorp JM Jr, Bowes WA Jr. Severe symmetric intrauterine growth retardation associated with the topical use of triamcinolone. Am J Obstet Gynecol. 1990;162:396-397.
36. Ost L, Wettrekk G, Bjorkhem I, et al. Prednisolone excretion into human milk. J Pediatr. 1985;106:1008-1011.
37. Grekas DM, Vasiliou SS, Lazarides AM. Immunosuppressive therapy and breast feeding affer renal transplantation. Nephrology. 1984;37:58.
38. Anderson PO. Corticosteroid use by breast-feeding mothers. Clin Pharmacy. 1987; 6:445.
39. DeStetano P, Bongo C, Borgna-Pignatti C, et al. Factitious hypertension with mineralocorticoid excess in an infant. Helv Paediatr Acta. 1983;38:185-189.